StockData
Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. (PBH) stock

PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$48.22+0.22 (+0.46%)

Close on Nov 17, 2026Market cap $2.28BP/E 13.5Yield –

Prestige Consumer Healthcare enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Prestige Consumer Healthcare's enterprise value was $4.06B on Nov 11, 2026, against $2.85B a year earlier. Over the last 5 years it ranged from $2.71B to $5.26B, with a median of $4.29B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.06B+37.4%
2025Dec 31, 2025$2.95B-40.1%
2024Dec 31, 2024$4.93B+15.7%
2023Dec 29, 2023$4.26B-7.2%
2022Dec 30, 2022$4.59B-1.3%
2021Dec 31, 2021$4.65B+41.2%
2020Dec 31, 2020$3.29B-13.8%
2019Dec 31, 2019$3.82B+9.4%
2018Dec 31, 2018$3.49B-21.0%
2017Dec 29, 2017$4.42B+4.8%
2016Dec 30, 2016$4.22B+1.1%
2015Dec 31, 2015$4.17B+19.5%
2014Dec 31, 2014$3.49B+24.3%
2013Dec 31, 2013$2.81B+35.6%
2012Dec 31, 2012$2.07B+105.2%
2011Dec 30, 2011$1.01B+81.2%
2010Dec 31, 2010$557.42M–

More Prestige Consumer Healthcare figures

See a number that looks wrong?